JP2024506530A5 - - Google Patents
Info
- Publication number
- JP2024506530A5 JP2024506530A5 JP2023545262A JP2023545262A JP2024506530A5 JP 2024506530 A5 JP2024506530 A5 JP 2024506530A5 JP 2023545262 A JP2023545262 A JP 2023545262A JP 2023545262 A JP2023545262 A JP 2023545262A JP 2024506530 A5 JP2024506530 A5 JP 2024506530A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- aryl
- heterocyclyl
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21305085.9 | 2021-01-25 | ||
| EP21305085 | 2021-01-25 | ||
| PCT/EP2022/051650 WO2022157392A1 (en) | 2021-01-25 | 2022-01-25 | Use of indole, 6- and 7-azaindole derivatives as inhibitors of ferroptosis regulated cell death |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506530A JP2024506530A (ja) | 2024-02-14 |
| JP2024506530A5 true JP2024506530A5 (https=) | 2025-01-31 |
Family
ID=74553738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545262A Pending JP2024506530A (ja) | 2021-01-25 | 2022-01-25 | フェロトーシス制御性細胞死の阻害剤としてのインドール、６－および７－アザインドール誘導体の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240116923A1 (https=) |
| EP (1) | EP4281070A1 (https=) |
| JP (1) | JP2024506530A (https=) |
| CN (1) | CN117529317A (https=) |
| CA (1) | CA3205853A1 (https=) |
| WO (1) | WO2022157392A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250127084A (ko) | 2022-12-02 | 2025-08-26 | 시비라이프 | 조절된 괴사 억제제와 n-아세틸시스테인의 상승작용적 조합 |
| WO2025078659A1 (en) | 2023-10-12 | 2025-04-17 | Seabelife | Method and kit for inducing cell differentiation, and regulated necrotic cell death inhibitor for use for regenerating damaged tissues |
| WO2025206255A1 (ja) * | 2024-03-29 | 2025-10-02 | 富士フイルム株式会社 | 被験物質の評価方法および被験物質の評価キット |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011248175A1 (en) * | 2010-05-06 | 2012-10-25 | Merck Sharp & Dohme Corp. | Aza-Indole derivatives useful as modulators of FAAH |
| WO2017054216A1 (zh) * | 2015-10-01 | 2017-04-06 | 史利利 | 电磁炉及线圈盘 |
| WO2017064216A1 (en) * | 2015-10-13 | 2017-04-20 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | N1- and n7-substituted sibiriline derivatives and their use as inhibitor of cellular necroptosis |
| ES2885474T3 (es) * | 2015-10-13 | 2021-12-13 | Inst Nat Sante Rech Med | Derivados de sibirilina para la utilización en la prevención y/o tratamiento de trastornos asociados a la necroptosis celular |
| WO2019106434A1 (en) * | 2017-12-01 | 2019-06-06 | Collaborative Medicinal Development Pty. Ltd. | Heterobicyclic aromatic derivatives for the treatment of ferroptosis-related disorders |
| AU2019390478A1 (en) * | 2018-11-27 | 2021-07-08 | The Trustees Of Columbia University In The City Of New York | Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders |
| BR112021017831A2 (pt) * | 2019-03-11 | 2021-11-30 | Collaborative Medicinal Dev Llc | Derivados heteroaromáticos e aromáticos heterobicíclicos para o tratamento de distúrbios relacionados com ferroptose |
-
2022
- 2022-01-25 WO PCT/EP2022/051650 patent/WO2022157392A1/en not_active Ceased
- 2022-01-25 CA CA3205853A patent/CA3205853A1/en active Pending
- 2022-01-25 US US18/273,878 patent/US20240116923A1/en active Pending
- 2022-01-25 CN CN202280024110.4A patent/CN117529317A/zh active Pending
- 2022-01-25 JP JP2023545262A patent/JP2024506530A/ja active Pending
- 2022-01-25 EP EP22702235.7A patent/EP4281070A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024506530A5 (https=) | ||
| AU2018202865B2 (en) | Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| JP2010502675A5 (https=) | ||
| JP2020523351A5 (https=) | ||
| ES2405054T3 (es) | Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato | |
| JP5576485B2 (ja) | 新生物疾患又は自己免疫疾患を処置するためのプロドラッグとしてのフラザノベンゾイミダゾール | |
| JP2010540593A5 (https=) | ||
| JP2013526494A5 (https=) | ||
| JP2009508949A5 (https=) | ||
| TN2010000256A1 (en) | Organic compound | |
| PL200955B1 (pl) | Przeciwwirusowa kompozycja farmaceutyczna i jej zastosowanie oraz zawierająca azot heterocykliczna pochodna karboksamidu | |
| JP2006513221A5 (https=) | ||
| CA2496844A1 (en) | Dihydropyridine derivatives for use as human neutrophil elastase inhibitors | |
| JP2006528980A5 (https=) | ||
| JP2008517915A5 (https=) | ||
| AR054787A1 (es) | Derivados de piperidinas utiles como antagonistas de histamina h3 | |
| TW200806652A (en) | N-hydroxyacrylamide compounds | |
| JP2013542267A5 (https=) | ||
| ES2548258T3 (es) | Compuestos de oxadiazol sustituidos y su uso como agonistas de S1P1 | |
| JP2022533939A5 (https=) | ||
| CZ289376B6 (cs) | Substituované benzamidiny, způsob jejich výroby a farmaceutický prostředek s jejich obsahem | |
| EP4457214A2 (en) | Dimethyltryptamine analogues as nitric oxide delivery drugs | |
| CA2666975C (en) | Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same | |
| JP2019537577A5 (https=) | ||
| JP2022552019A5 (https=) |